PYXUS INTERNATIONAL, INC., 10-Q filed on 8/5/2026
Quarterly Report
v3.26.1
Cover - shares
3 Months Ended
Jun. 30, 2026
Jul. 31, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Transition Report false  
Entity File Number 000-25734  
Entity Registrant Name Pyxus International, Inc.  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 85-2386250  
Entity Address, Address Line One 6001 Hospitality Court, Suite 100  
Entity Address, City or Town Morrisville,  
Entity Address, State or Province NC  
Entity Address, Postal Zip Code 27560  
City Area Code 919  
Local Phone Number 379-4300  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   24,607,791
Entity Central Index Key 0000939930  
Document Fiscal Year Focus 2027  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]    
Sales and other operating revenues $ 437,795 $ 508,815
Cost of goods and services sold 376,381 443,189
Gross profit 61,414 65,626
Selling, general, and administrative expenses 43,935 40,369
Other expense, net 1,257 4,176
Restructuring and asset impairment charges 557 81
Operating income 15,665 21,000
Interest expense, net 29,842 29,767
Loss before income taxes and other items (14,177) (8,767)
Income tax (benefit) expense (5,716) 5,227
Income (loss) from unconsolidated affiliates, net 1,422 (1,269)
Net loss (7,039) (15,263)
Net income attributable to noncontrolling interests 241 562
Net loss attributable to Pyxus International, Inc. $ (7,280) $ (15,825)
Loss per share:    
Basic (in USD per share) $ (0.28) $ (0.62)
Diluted (in USD per share) $ (0.28) $ (0.62)
Weighted average number of shares outstanding:    
Basic (in shares) 26,056 25,670
Diluted (in shares) 26,056 25,670
v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]    
Net loss $ (7,039) $ (15,263)
Other comprehensive income, net of tax:    
Foreign currency translation adjustment (114) 2,039
Cash flow hedges 589 1,457
Total other comprehensive income, net of tax 475 3,496
Total comprehensive loss (6,564) (11,767)
Comprehensive income attributable to noncontrolling interests 241 562
Comprehensive loss attributable to Pyxus International, Inc. $ (6,805) $ (12,329)
v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Current assets      
Cash and cash equivalents $ 175,907 $ 134,337 $ 96,437
Restricted cash 3,642 3,316 4,945
Trade receivables, net 175,667 239,456 206,607
Other receivables 10,897 25,451 16,683
Inventories, net 1,104,637 817,950 1,121,788
Advances to tobacco suppliers, net 88,132 36,337 61,737
Recoverable income taxes 14,366 2,886 11,670
Prepaid expenses 59,366 49,000 50,011
Other current assets 20,334 21,751 21,123
Total current assets 1,652,948 1,330,484 1,591,001
Investments in unconsolidated affiliates 96,174 105,863 95,659
Intangible assets, net 22,984 24,076 27,387
Deferred income taxes, net 14,620 14,507 13,181
Long-term recoverable income taxes 10,157 9,467 4,956
Other noncurrent assets 44,082 35,424 39,315
Right-of-use assets 34,858 31,717 32,033
Property, plant, and equipment, net 141,431 143,154 136,993
Total assets 2,017,254 1,694,692 1,940,525
Current liabilities      
Notes payable 828,553 477,132 880,925
Accounts payable 114,644 146,828 124,341
Advances from customers 166,718 174,995 87,374
Accrued expenses and other current liabilities 131,506 114,760 104,162
Income taxes payable 10,838 9,145 10,449
Operating leases payable 10,064 9,915 9,565
Total current liabilities 1,262,323 932,775 1,216,816
Long-term taxes payable 4,807 4,112 6,195
Long-term debt 456,020 455,757 455,091
Deferred income taxes 8,128 11,961 8,902
Liability for unrecognized tax benefits 29,507 28,074 21,935
Long-term leases 22,044 21,020 19,541
Pension, postretirement, and other long-term liabilities 59,600 59,886 57,805
Total liabilities 1,842,429 1,513,585 1,786,285
Commitments and contingencies
Common Stock      
Common Stock—no par value: Authorized shares (250,000 for all periods) Issued and outstanding shares (24,608 for all periods) 394,203 393,921 393,136
Retained deficit (232,836) (225,556) (255,950)
Accumulated other comprehensive income 6,598 6,123 10,811
Total stockholders’ equity of Pyxus International, Inc. 167,965 174,488 147,997
Noncontrolling interests 6,860 6,619 6,243
Total stockholders’ equity 174,825 181,107 154,240
Total liabilities and stockholders’ equity $ 2,017,254 $ 1,694,692 $ 1,940,525
v3.26.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Statement of Financial Position [Abstract]      
Common stock, no par value (in USD per share) $ 0 $ 0 $ 0
Common stock, shares authorized (in shares) 250,000,000 250,000,000 250,000,000
Common stock, shares, issued (in shares) 24,608,000 24,608,000 24,608,000
Common stock, shares, outstanding (in shares) 24,608,000 24,608,000 24,608,000
v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Retained Deficit
Currency Translation Adjustment
Pensions, Net of Tax
Derivatives, Net of Tax
Noncontrolling Interests
Balance at beginning of period at Mar. 31, 2025 $ 165,770 $ 392,899 $ (240,125) $ (6,045) $ 12,516 $ 844 $ 5,681
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (15,263)   (15,825)       562
Equity-based compensation 237 237          
Other comprehensive income, net of tax 3,496     2,039   1,457  
Balance at end of period at Jun. 30, 2025 154,240 393,136 (255,950) (4,006) 12,516 2,301 6,243
Balance at beginning of period at Mar. 31, 2026 181,107 393,921 (225,556) (5,109) 10,224 1,008 6,619
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (7,039)   (7,280)       241
Equity-based compensation 282 282          
Other comprehensive income, net of tax 475     (114)   589  
Balance at end of period at Jun. 30, 2026 $ 174,825 $ 394,203 $ (232,836) $ (5,223) $ 10,224 $ 1,597 $ 6,860
v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities:    
Net loss $ (7,039) $ (15,263)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,628 5,169
Debt amortization/interest 2,079 2,592
Loss on foreign currency transactions 801 7,725
Equity-based compensation 282 237
Income (loss) from unconsolidated affiliates, net of dividends 9,689 1,269
Changes in operating assets and liabilities, net    
Trade and other receivables 9,568 (52,367)
Inventories and advances to tobacco suppliers (339,578) (388,020)
Deferred items (1,950) 4,529
Recoverable income taxes (12,337) (4,477)
Payables and accrued expenses (13,776) 393
Advances from customers (6,747) (49,806)
Prepaid expenses (7,628) (2,660)
Income taxes 1,490 (838)
Other operating assets and liabilities 482 2,000
Other, net (672) (5,770)
Net cash used in operating activities (359,708) (495,287)
Investing Activities:    
Purchases of property, plant, and equipment (4,186) (4,279)
Collections from beneficial interests in securitized trade receivables 58,540 41,007
Other, net 233 913
Net cash provided by investing activities 54,587 37,641
Financing Activities:    
Net proceeds from short-term borrowings 353,603 476,945
Proceeds from revolving loan facilities 45,000 81,000
Repayment of revolving loan facilities (45,000) (81,000)
Debt issuance costs (5,134) (2,825)
Other, net 0 361
Net cash provided by financing activities 348,469 474,481
Effect of exchange rate changes on cash (1,452) (997)
Increase in cash, cash equivalents, and restricted cash 41,896 15,838
Cash and cash equivalents at beginning of period 134,337 78,254
Restricted cash at beginning of period 3,316 7,290
Cash, cash equivalents, and restricted cash at end of period 179,549 101,382
Other information:    
Cash paid for income taxes, net 3,886 2,609
Cash paid for interest, net 27,108 25,988
Noncash investing activities:    
Noncash amounts obtained as a beneficial interest in exchange for transferring trade receivables in a securitization transaction $ 28,595 $ 30,017
v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies
3 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
The accompanying unaudited condensed consolidated interim financial statements represent the consolidation of Pyxus International, Inc. (the "Company," "Pyxus," "we," "us," or "our") and all companies that Pyxus directly or indirectly controls, either through majority ownership or otherwise. These condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, the normal and recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows have been included.

These condensed consolidated interim financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2026 filed on June 4, 2026. The year-end condensed consolidated balance sheet data was derived from the audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. Due to the seasonal nature of the Company’s business, the results of operations for a fiscal quarter are not necessarily indicative of the operating results that may be attained for other quarters or a full fiscal year.
v3.26.1
New Accounting Standards
3 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
New Accounting Standards New Accounting Standards
Accounting Pronouncements Not Yet Adopted
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2024-03, Disaggregation of Income Statement Expenses, which requires a tabular disclosure of relevant expense captions into prescribed natural expense categories. The annual disclosure requirements are effective for the Company’s fiscal year ending March 31, 2028, and the interim period disclosure requirements are effective beginning April 1, 2028. Early adoption is permitted. This new standard will result in additional disclosures within the footnotes to the financial statements, and is not expected to have an impact on the Company’s financial condition, results of operations, or cash flows.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software, which replaces the existing model used to determine when cost capitalization is to occur based on various project stages of software development with a more modern approach that introduces a probable-to-complete recognition threshold. The scope of this new guidance also includes the costs an entity incurs to implement a cloud computing arrangement as a customer. This amendment is effective for the Company's annual and interim periods beginning April 1, 2028. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.

In November 2025, the FASB issued ASU No. 2025-09, Hedge Accounting Improvements, to clarify certain aspects of existing hedge accounting guidance, and to more closely align hedge accounting with the economics of an entity's risk management activities. This amendment is effective for the Company’s annual and interim periods beginning April 1, 2027 and requires adoption on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.

In December 2025, the FASB issued ASU No. 2025-10, Accounting for Government Grants Received by Business Entities, to establish guidance on the recognition, measurement, and presentation of government grants received by business entities. This new guidance is effective for the Company’s fiscal year beginning April 1, 2029, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.
v3.26.1
Revenue Recognition
3 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Product revenues are primarily processed tobacco sold to the customer. Processing and other revenues are mainly contracts to process customer-owned green tobacco. During such processing, ownership remains with the customers. All Other revenue is primarily composed of revenue from the sale of non-tobacco agriculture products. The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:

Three Months Ended
June 30,
20262025
Leaf:
Product revenues$392,976 $458,238 
Processing and other revenues42,836 50,177 
Leaf sales and other operating revenues435,812 508,415 
All Other:
All Other sales and other operating revenues1,983 400 
Total sales and other operating revenues$437,795 $508,815 
v3.26.1
Income Taxes
3 Months Ended
Jun. 30, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company’s (benefit from) provision for income taxes for the three months ended June 30, 2026 and 2025 was calculated by applying the estimated annual effective tax rate to year-to-date pre-tax loss and adjusting for discrete items that occurred during the period.

The effective tax rate for the three months ended June 30, 2026 and 2025 was a benefit of 40.3% and an expense of 59.6%, respectively. For the three months ended June 30, 2026, the difference between the Company's effective tax rate and the U.S. statutory rate of 21.0% is primarily due to a tax benefit related to foreign currency losses and the jurisdictional mix of earnings, partially offset by an increase in the Company’s deferred tax valuation allowance.
v3.26.1
Loss Per Share
3 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Loss Per Share Loss Per Share
The following summarizes the computation of loss per share:

Three Months Ended
June 30,
20262025
Net loss attributable to Pyxus International, Inc.$(7,280)$(15,825)
Basic weighted average shares outstanding26,056 25,670 
Plus: Dilutive equity awards(1)
— — 
Diluted weighted average shares outstanding26,056 25,670 
Loss per share:
Basic$(0.28)$(0.62)
Diluted$(0.28)$(0.62)
(1) For the three months ended June 30, 2026 and 2025, 34 shares and 264 shares, respectively, related to outstanding restricted stock units have been excluded from the computation of diluted earnings per share because their effect would be antidilutive.
v3.26.1
Trade Receivables, Net
3 Months Ended
Jun. 30, 2026
Receivables [Abstract]  
Trade Receivables, Net Trade Receivables, Net
Trade receivables are net of an allowance for expected credit losses. The following summarizes activity in the allowance for expected credit losses:

Three Months Ended
June 30,
20262025
Balance, beginning of period$(16,879)$(24,035)
Write-offs and other adjustments431 (264)
Balance, end of period(16,448)(24,299)
Trade receivables192,115 230,906 
Trade receivables, net$175,667 $206,607 
v3.26.1
Inventories, Net
3 Months Ended
Jun. 30, 2026
Inventory Disclosure [Abstract]  
Inventories, Net Inventories, Net
The following summarizes the composition of inventories, net, with the All Other category primarily composed of non-tobacco agricultural products:

June 30, 2026June 30, 2025March 31, 2026
Processed tobacco$671,617 $575,922 $507,380 
Unprocessed tobacco393,542 513,882 279,348 
Other tobacco related27,847 26,089 26,883 
All Other
11,631 5,895 4,339 
Total$1,104,637 $1,121,788 $817,950 
v3.26.1
Equity Method Investments
3 Months Ended
Jun. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments Equity Method Investments
The following summarizes the Company's equity method investments as of June 30, 2026:

Investee NameLocationPrimary PurposeOwnership Percentage
Basis Difference(1)
Adams International Ltd.ThailandPurchase and process tobacco49%$(4,526)
Alliance One Industries India Private Ltd.IndiaPurchase and process tobacco49%(5,770)
China Brasil Tabacos Exportadora S.A.BrazilPurchase and process tobacco49%43,000 
Oryantal Tütün Paketleme Sanayi ve Ticaret A.Ş.TurkeyProcess tobacco50%(416)
Purilum, LLCU.S.Produce flavor formulations and consumable nicotine products50%4,589 
Siam Tobacco Export Corporation Ltd.ThailandPurchase and process tobacco49%(6,098)
(1) Basis differences for the Company's equity method investments are due to fair value adjustments recorded during fiscal 2021.

The following summarizes financial information for these equity method investments:

Three Months Ended
June 30,
20262025
Statement of operations:
Sales$52,156 $46,504 
Gross profit6,256 7,052 
Net income (loss)3,007 (2,666)
June 30, 2026June 30, 2025March 31, 2026
Balance sheet:
Current assets$455,993 $510,324 $457,219 
Property, plant, and equipment and other assets67,568 51,932 65,716 
Current liabilities383,467 425,697 362,790 
Long-term obligations and other liabilities5,886 4,150 6,333 
v3.26.1
Variable Interest Entities
3 Months Ended
Jun. 30, 2026
Variable Interest Entities [Abstract]  
Variable Interest Entities Variable Interest Entities
The Company holds variable interests in multiple entities that primarily procure or process inventory or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The following summarizes the Company's financial relationships with its unconsolidated variable interest entities:

June 30, 2026June 30, 2025March 31, 2026
Investments in variable interest entities$89,676 $89,200 $99,239 
Receivables with variable interest entities1,913 1,469 — 
Guaranteed amounts to variable interest entities (not to exceed)18,449 15,968 18,483 
v3.26.1
Intangible Assets, Net
3 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Intangible Assets, Net Intangible Assets, Net
The gross carrying amount and accumulated amortization of intangible assets consist of the following:

June 30, 2026
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships6.2 years$26,101 $(12,688)$13,413 
Technology2.2 years11,618 (8,639)2,979 
Trade names8.2 years11,300 (4,708)6,592 
Total$49,019 $(26,035)$22,984 

June 30, 2025
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships7.2 years$26,101 $(10,513)$15,588 
Technology3.1 years11,618 (7,218)4,400 
Trade names9.2 years11,300 (3,901)7,399 
Total$49,019 $(21,632)$27,387 
March 31, 2026
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships6.4 years$26,101 $(12,144)$13,957 
Technology2.4 years11,618 (8,292)3,326 
Trade names8.4 years11,300 (4,507)6,793 
Total$49,019 $(24,943)$24,076 

The following summarizes amortization expense for definite-lived intangible assets:

Three Months Ended
June 30,
20262025
Amortization expense$1,092 $1,120 
v3.26.1
Debt Arrangements
3 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Debt Arrangements Debt Arrangements
The following summarizes debt and notes payable:

Interest Rate(1)
June 30, 2026June 30, 2025March 31, 2026
Senior secured credit facility:
ABL Credit Facility6.7 %$— $— $— 
Senior secured notes:
8.5% Notes Due 2027(2)
8.5 %146,908 146,046 146,662 
Senior secured term loans:
Intabex Term Loans(3)
12.2 %187,916 187,288 187,752 
Pyxus Term Loans(4)
12.2 %121,196 121,757 121,343 
Other debt:
   Notes payable(5)
9.0 %828,553 880,925 477,132 
    Total debt$1,284,573 $1,336,016 $932,889 
Short-term(5)
$828,553 $880,925 $477,132 
Long-term456,020 455,091 455,757 
Letters of credit$8,273 $8,939 $8,024 
(1) Weighted average stated rate for the trailing twelve months ended June 30, 2026 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.
(2) Balance of $146,908 is net of a debt discount of $1,431. Total repayment at maturity is $148,339.
(3) Balance of $187,916 is net of a debt discount of $1,117. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(4) Balance of $121,196 is net of a debt premium of $991. Total repayment at maturity is $120,205.
(5) Primarily foreign seasonal lines of credit.

Outstanding Senior Secured Debt

ABL Credit Facility
The Company’s wholly owned subsidiary, Pyxus Holdings, Inc. ("Pyxus Holdings"), certain subsidiaries of Pyxus Holdings (together with Pyxus Holdings, the "Borrowers"), and the Company and its wholly owned subsidiary, Pyxus Parent, Inc. ("Pyxus Parent"), as parent guarantors, entered into an ABL Credit Agreement (as amended, the "ABL Credit Agreement"), dated as of February 8, 2022, by and among Pyxus Holdings, as Borrower Agent, the Borrowers and parent guarantors party thereto, the lenders party thereto, and PNC Bank, National Association, as Administrative Agent and Collateral Agent, to establish an asset-based revolving credit facility (the "ABL Credit Facility"). The ABL Credit Facility may be used for revolving credit loans and letters of credit from time to time up to a maximum principal amount of $150,000, subject to certain borrowing base limitations. The ABL Credit Facility includes a $20,000 uncommitted accordion feature that permits Pyxus Holdings, under certain conditions, to solicit the lenders under the ABL Credit Facility to provide additional revolving loan commitments to increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility not to exceed a maximum principal amount of $170,000.

The ABL Credit Facility matures on May 12, 2030 or, if earlier, 90 days prior to the earliest stated maturity date of the outstanding senior secured notes and the senior secured term loans (each currently scheduled to mature on December 31, 2027). At June 30, 2026, the Borrowers and the parent guarantors under the ABL Credit Agreement were in compliance with the covenants under the ABL Credit Agreement.

Intabex Term Loans
The Intabex Term Loan Credit Agreement, dated as of February 6, 2023 (the "Intabex Term Loan Credit Agreement"), is by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus (US) LLC ("Alter Domus"), as administrative agent and senior collateral agent. The Intabex Term Loan Credit Agreement established a term loan
credit facility in an aggregate principal amount of approximately $189,033 (the "Intabex Credit Facility"), under which term loans in the full aggregate principal amount of the Intabex Credit Facility (the "Intabex Term Loans") were deemed made in exchange for certain outstanding term debt of Pyxus Holdings, accrued and unpaid PIK interest thereon, and related fees. The Intabex Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Intabex Term Loans are stated to mature on December 31, 2027. At June 30, 2026, Pyxus Holdings and the guarantors under the Intabex Term Loan Credit Agreement were in compliance with all covenants under the Intabex Term Loan Credit Agreement.

Pyxus Term Loans
The Pyxus Term Loan Credit Agreement, dated as of February 6, 2023 (the "Pyxus Term Loan Credit Agreement"), is by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus, as administrative agent and senior collateral agent. It established a term loan credit facility in an aggregate principal amount of approximately $130,550 (the "Pyxus Credit Facility"), under which term loans in the full aggregate principal amount of the Pyxus Credit Facility (the "Pyxus Term Loans") were deemed made in exchange for certain outstanding term debt of Pyxus Holdings and applicable accrued and unpaid PIK interest thereon. The Pyxus Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Pyxus Term Loans are stated to mature on December 31, 2027. At June 30, 2026, Pyxus Holdings and the guarantors under the Pyxus Term Loan Credit Agreement were in compliance with all covenants under the Pyxus Term Loan Credit Agreement.

8.50% Senior Secured Notes due 2027
Pursuant to an exchange offer made by Pyxus Holdings and accepted by holders of approximately 92.7% of the aggregate principal amount of the outstanding 10.0% Senior Secured First Lien Notes due 2024 issued by Pyxus Holdings (the "2024 Notes") pursuant to that certain Indenture, dated as of August 24, 2020 (the "2024 Notes Indenture"), by and among Pyxus Holdings, the guarantors party thereto and the trustee, collateral agent, registrar and paying agent thereunder, on February 6, 2023, Pyxus Holdings issued approximately $260,452 in aggregate principal amount of 8.5% Senior Secured Notes due December 31, 2027 (the "2027 Notes") to the exchanging holders of the 2024 Notes for an equal principal amount of 2024 Notes. The 2027 Notes were issued pursuant to the Indenture, dated as of February 6, 2023 (the "2027 Notes Indenture"), among Pyxus Holdings, the guarantors party thereto, and Wilmington Trust, National Association, as trustee, and Alter Domus, as collateral agent. The 2027 Notes bear interest at a rate of 8.5% per annum, which interest is computed on the basis of a 360-day year comprised of twelve 30-day months. At June 30, 2026, Pyxus Holdings and the guarantors of the 2027 Notes were in compliance with all covenants under the 2027 Notes Indenture.

Detailed descriptions of the instruments governing the Company's outstanding senior secured debt are included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

Other Outstanding Debt

Foreign Seasonal Lines of Credit
Excluding long-term credit agreements, the Company typically finances its foreign operations with committed and uncommitted short-term seasonal lines of credit arrangements with a number of banks. These operating lines are generally seasonal in nature, typically extending for a term of 180 days to 365 days corresponding to the tobacco crop cycle in that location. For uncommitted facilities, the lenders have the right to cease making loans and demand repayment of loans at any time or at specified dates. These loans are generally renewed at the outset of each tobacco season. Certain of the seasonal lines of credit are secured by trade receivables and inventories as collateral and are guaranteed by the Company and certain of its subsidiaries. At June 30, 2026, the Company was permitted to borrow under foreign seasonal lines of credit up to a total $1,170,392, subject to limitations under the ABL Credit Agreement and the agreements governing the Intabex Term Loans, the Pyxus Term Loans, and the 2027 Notes. As of June 30, 2026, the total borrowing capacity under individual foreign seasonal lines of credit range up to $150,630. As of June 30, 2026, the aggregate amount available for borrowing under the seasonal lines of credit was $351,395. At June 30, 2026, the Company, and its subsidiaries, were in compliance with the covenants associated with its short-term foreign seasonal lines of credit.
v3.26.1
Securitized Receivables
3 Months Ended
Jun. 30, 2026
Transfers and Servicing [Abstract]  
Securitized Receivables Securitized Receivables
The Company sells trade receivables to unaffiliated financial institutions under various accounts receivable securitization facilities, two of which are subject to annual renewal.

Under the first facility with Finacity Corporation (the "Finacity Facility"), the Company continuously sells a designated pool of trade receivables to a special purpose entity, which sells 100% of the receivables to an unaffiliated financial institution. Following the sale and transfer of the receivables to the special purpose entity, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights,
including the right to pledge or sell the receivables. This facility requires a minimum level of deferred purchase price be retained by the Company in connection with the sales of the receivables to the unaffiliated financial institution. The Company continues to service, administer, and collect the receivables on behalf of the special purpose entity and receives a servicing fee of 0.5% of serviced receivables per annum. The Company estimates the expected fee it receives in return for its obligation to service these receivables reflects fair value, and accordingly, no servicing assets or liabilities are recognized. Servicing fees are recorded as a reduction of selling, general, and administrative expenses within the condensed consolidated statements of operations. Under this facility, the Company may request a temporary increase in the investment limit up to an additional $40,000, applicable only for the period from January 1, 2027 through May 31, 2027. As of June 30, 2026, the investment limit of this facility was $120,000 of trade receivables.

Under the second facility, the Company offers trade receivables for sale to an unaffiliated financial institution, which are then subject to acceptance by the unaffiliated financial institution. Following the sale and transfer of the receivables to the unaffiliated financial institution, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights, including the right to pledge or sell the receivables. Although the Company continues to service, administer, and collect the receivables on behalf of the unaffiliated financial institution, the Company does not receive a servicing fee, and as a result, has established a servicing liability based upon unobservable inputs, primarily discounted cash flow. As of June 30, 2026, the investment limit under the second facility was $160,000 of trade receivables.

As servicer for the Finacity Facility and the second facility, the Company may receive funds that are due to the unaffiliated financial institutions which are net settled on the next settlement date. As of June 30, 2026 and 2025, and March 31, 2026, trade receivables, net in the condensed consolidated balance sheets have been reduced by $10,817, $1,056, and $13,610 as a result of the net settlement, respectively. As of June 30, 2026 and 2025, and March 31, 2026, accrued expenses and other current liabilities in the condensed consolidated balance sheets include $15,681, $0, and $0 of net payables for the Finacity Facility. See "Note 15. Fair Value Measurements" for additional information.

Under the other facilities, the Company offers trade receivables for sale to unaffiliated financial institutions, which are then subject to acceptance by the unaffiliated financial institutions. Following the sale and transfer of the receivables to the unaffiliated financial institution, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights, including the right to pledge or sell the receivables. As of June 30, 2026, the investment limits under these other facilities were variable based on qualifying sales.

The following summarizes the Company’s accounts receivable outstanding in the securitization facilities, which represents trade receivables sold into the program that have not been collected from the customer, and related beneficial interests, applicable only to the first and second facilities, which represents the Company’s residual interest in receivables sold that have not been collected from the customer:

June 30, 2026June 30, 2025March 31, 2026
Receivables outstanding in facility$121,227 $167,433 $341,679 
Beneficial interests10,817 16,103 29,034 

Cash proceeds from the sale of trade receivables are comprised of an initial cash payment received at the time of transfer and a deferred purchase price receivable, applicable only to the first and second facilities, which represents the Company's right to receive the remaining consideration upon collection of the underlying trade receivables by the purchasers. The following summarizes the Company’s cash collections from both the initial cash proceeds and the deferred purchase price receivable:

Three Months Ended
June 30,
20262025
Cash collections from:
Initial proceeds$91,144 $115,034 
Deferred purchase price receivable58,540 41,007 
v3.26.1
Guarantees
3 Months Ended
Jun. 30, 2026
Guarantees [Abstract]  
Guarantees Guarantees
In certain sourcing regions, the Company guarantees bank loans for suppliers to finance their crops. The Company also guarantees bank loans of certain unconsolidated affiliates. See "Note 15. Fair Value Measurements" for the fair value of the Company's guarantee liability and corresponding fair value classification. The following summarizes amounts guaranteed:

June 30, 2026June 30, 2025March 31, 2026
Amounts guaranteed (not to exceed)$90,251 $83,519 $119,728 
Amounts outstanding under guarantee(1)
56,974 47,948 92,550 
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing7,691 7,478 10,204 
(1) The majority of the guarantees outstanding at June 30, 2026 expire within one year.
v3.26.1
Derivative Financial Instruments
3 Months Ended
Jun. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company is exposed to foreign currency exchange rate risk related to its international operations. Principal currencies hedged include the Brazilian real and the Malawian kwacha. The Company uses forward or option currency contracts to manage risks associated with changes in foreign currency exchange rates. These derivative contracts are either designated as cash flow hedges of forecasted transactions for the purchase of green tobacco, other processing-related costs, and selling, general, and administrative expenses, or are not designated as hedging instruments because they are used to partially offset the immediate earnings impact of exchange rate risk on certain foreign currency denominated transactions.

As of June 30, 2026 and 2025, and March 31, 2026, the Company's derivative financial instruments outstanding were designated as cash flow hedges. See "Note 15. Fair Value Measurements" for the fair values of the Company's outstanding derivative assets and liabilities and corresponding fair value classifications.

The following summarizes the U.S. dollar notional amount of derivative contracts outstanding:

June 30, 2026June 30, 2025March 31, 2026
Foreign currency exchange contracts$49,267 $14,250 $54,100 

The following summarizes the pre-tax effects of derivative financial instruments in the condensed consolidated statements of comprehensive loss and the condensed consolidated statements of operations:

Three Months Ended
June 30,
20262025
Foreign currency exchange contracts designated as cash flow hedges:
Gain recognized in accumulated other comprehensive income(1)
$1,298 $3,354 
Gain reclassified from accumulated other comprehensive income to earnings(2)
406 1,147 
Foreign currency exchange contracts not designated as hedging instruments:
Gain recognized in earnings(2)
$— $721 
(1) Amount represents the net change in fair value of derivative financial instruments.
(2) These net gains are recognized in cost of goods and services sold within the condensed consolidated statements of operations.
v3.26.1
Fair Value Measurements
3 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following summarizes the financial assets and liabilities measured at fair value on a recurring basis, along with their corresponding level within the fair value hierarchy:    

June 30, 2026June 30, 2025March 31, 2026
Level 2Level 3Total
at Fair
Value
Level 2Level 3Total
at Fair
Value
Level 2Level 3Total
at Fair
Value
Financial Assets:
Derivative financial instruments$153 $— $153 $1,322 $— $1,322 $649 $— $649 
Securitized beneficial interests— 10,817 10,817 — 16,103 16,103 — 29,034 29,034 
Total assets$153 $10,817 $10,970 $1,322 $16,103 $17,425 $649 $29,034 $29,683 
Financial Liabilities:
Derivative financial instruments$100 $— $100 $— $— $— $— $— $— 
Long-term debt(1)
433,396 — 433,396 439,316 — 439,316 433,490 — 433,490 
Guarantees— 4,524 4,524 — 3,287 3,287 — 7,537 7,537 
Total liabilities$433,496 $4,524 $438,020 $439,316 $3,287 $442,603 $433,490 $7,537 $441,027 
(1) This fair value measurement disclosure does not affect the condensed consolidated balance sheets.

The following summarizes the changes in Level 3 instruments measured on a recurring basis:

Three Months Ended
June 30, 2026June 30, 2025
Securitized Beneficial InterestsLong-Term DebtGuaranteesSecuritized Beneficial InterestsLong-Term DebtGuarantees
Balance, beginning of period$29,034 $— $7,537 $29,354 $12 $6,459 
Issuances28,595 — 1,695 30,431 — 300 
Settlements(46,093)— (705)(42,023)(12)(1,242)
Losses recognized in earnings(719)— (4,003)(1,659)— (2,230)
Balance, end of period$10,817 $— $4,524 $16,103 $— $3,287 
v3.26.1
Contingencies and Other Information
3 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies and Other Information Contingencies and Other Information
Brazilian Tax Credits
The government in the Brazilian State of Parana ("Parana") issued a tax assessment on October 26, 2007 with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At June 30, 2026, the assessment for intrastate trade tax credits taken is $2,550 and the total assessment including penalties and interest is $11,538. The Company believes it has properly complied with Brazilian law and will contest any assessment through the judicial process. Should the Company lose in the judicial process, the loss of the intrastate trade tax credits would have a material impact on the financial statements of the Company.

Other Matters
In addition to the above-mentioned matter, the Company or certain of its subsidiaries are involved in other litigation or legal matters incidental to their business activities, including tax matters. While the outcome of these matters cannot be predicted with certainty, they are being vigorously defended and the Company does not currently expect that any of them will have a material adverse effect on its business or financial position. However, should one or more of these matters be resolved in a manner adverse to its current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.
v3.26.1
Equity-Based Compensation
3 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation Equity-Based Compensation
Pursuant to the Pyxus International, Inc. Amended and Restated 2020 Incentive Plan (the "Incentive Plan"), a total of 3,612 shares (which amounts are presented in thousands) have been authorized for grants of equity-based awards to certain employees and non-employee directors.

Restricted Stock Units
Restricted stock units granted under the Incentive Plan are earned ratably for certain employees, subject to their continued employment, from the date of the award to March 31, 2027, and for certain non-employee directors, subject to continued board service, from the date of the award to the Company's next annual meeting of shareholders. Restricted stock units vest upon the earlier of March 31, 2031 or the occurrence of a change-in-control event or a liquidity event as such terms are defined under the restricted stock unit award agreement. The following summarizes activity for restricted stock units:

(in thousands, except grant date fair value)Restricted Stock UnitsWeighted Average Grant Date Fair Value Per Share
Nonvested, March 31, 20261,749 $3.49 
Canceled or forfeited(8)3.50 
Nonvested, June 30, 20261,741 $3.49 

The following summarizes equity-based compensation expense for restricted stock units, which is recorded in selling, general, and administrative expenses within the condensed consolidated statements of operations:

Three Months Ended
June 30,
20262025
Equity-based compensation expense$282 $237 

Unrecognized compensation cost for restricted stock units is $668 as of June 30, 2026, and is expected to be recognized over a weighted average period of 0.72 years, representing the weighted average remaining service period related to the awards, subject to adjustments for actual forfeitures.

Performance-Based Stock Units
Under the terms of the performance-based stock units, the amount of shares to be issued to certain employees (ranging from 0% to 200% of the number of shares to be issued at the target performance level) will be contingent upon the per share price achieved in a liquidity event (as defined under the terms of the performance-based stock unit award agreement), subject to continued employment through the date of a liquidity event. The contingent liquidity event is not probable as of June 30, 2026, and accordingly, no equity-based compensation expense has been recognized for performance-based stock units. The following summarizes activity for performance-based stock units (at the target performance level):

(in thousands, except grant date fair value)Performance-Based Stock UnitsWeighted Average Grant Date Fair Value Per Share
Nonvested, March 31, 2026508 $4.47 
Canceled or forfeited(19)4.36 
Nonvested, June 30, 2026489 $4.47 
v3.26.1
Related Party Transactions
3 Months Ended
Jun. 30, 2026
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
The Company engages in transactions with its equity method investees primarily for the procuring and processing of inventory. The following summarizes activities with the Company's equity method investees:

Three Months Ended
June 30,
20262025
Sales$7,791 $9,055 
Purchases20,385 27,309 
Dividends11,111 — 

The Company included the following related party balances in its condensed consolidated balance sheets:

June 30, 2026June 30, 2025March 31, 2026Location in Condensed Consolidated Balance Sheet
Accounts receivable, related parties$1,963 $1,519 $62 Other receivables
Accounts payable, related parties11,933 18,286 39,317 Accounts payable
Advances from related parties— 5,909 — Advances from customers

Transactions with Significant Shareholders
Based on a Schedule 13D/A filed with the SEC on June 13, 2024 by Glendon Capital Management, L.P. (the "Glendon Investor"), Holly Kim Olsen, Glendon Opportunities Fund, L.P. and Glendon Opportunities Fund II, L.P., the Glendon Investor reported beneficial ownership of 8,315 shares of the Company’s common stock, representing approximately 33.8% of the outstanding shares of the Company’s common stock. A representative of the Glendon Investor serves as a director of Pyxus. Based on a Schedule 13D/A filed with the SEC on March 25, 2024, by Monarch Alternative Capital LP (the "Monarch Investor"), MDRA GP LP and Monarch GP LLC, the Monarch Investor reported beneficial ownership of 6,125 shares of the Company’s common stock, representing approximately 24.9% of the outstanding shares of the Company’s common stock. An individual designated by the Monarch Investor serves as a director of Pyxus. Based on a Schedule 13G/A filed with the SEC on September 3, 2024 by Owl Creek Asset Management, L.P. and Jeffrey A. Altman, Owl Creek Asset Management, L.P. is the investment manager of certain funds and reported beneficial ownership of 3,865 shares of the Company’s common stock on August 31, 2024, representing approximately 15.7% of the outstanding shares of the Company’s common stock. During the three months ended June 30, 2026, funds managed by the Glendon Investor, funds managed by the Monarch Investor, and funds managed by Owl Creek Asset Management, L.P., (such funds are collectively referred to as the "Investor-Affiliated Funds") were holders, in part, of the Intabex Term Loans, the Pyxus Term Loans, and/or the 2027 Notes, which are described in "Note 11. Debt Arrangements."

Accrued expenses and other current liabilities as presented in the condensed consolidated balance sheets as of June 30, 2026 and 2025, and March 31, 2026, include $1,246, $1,499, and $1,352, respectively, of interest payable to Investor-Affiliated Funds. Interest expense as presented in the condensed consolidated statements of operations includes $5,182 and $5,466 for the three months ended June 30, 2026 and 2025, respectively, that relates to the Investor-Affiliated Funds.
v3.26.1
Segment Information
3 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The following summarizes financial information relating to the Leaf segment (the Company's sole reportable segment), with the All Other category included for purposes of reconciliation of the Leaf segment balances to the condensed consolidated financial statements:

Three Months Ended
June 30,
20262025
Sales and other operating revenues:
Leaf$435,812 $508,415 
All Other1,983 400 
Consolidated sales and other operating revenues$437,795 $508,815 
Cost of goods and services sold:
Leaf$375,691 $443,386 
All Other690 (197)
Consolidated cost of goods and services sold$376,381 $443,189 
Selling, general, and administrative expenses:
Leaf$42,631 $38,735 
All Other1,304 1,634 
Consolidated selling, general, and administrative expenses$43,935 $40,369 
Other segment items:(1)
Leaf$1,497 $4,205 
All Other(240)(29)
Consolidated other segment items$1,257 $4,176 
Leaf segment operating income$15,993 $22,089 
All Other operating income (loss)229 (1,008)
Restructuring and asset impairment charges557 81 
Consolidated operating income$15,665 $21,000 
Interest expense, net29,842 29,767 
Loss before income taxes and other items$(14,177)$(8,767)
(1) Represents the other expense, net caption within the condensed consolidated statements of operations.

Three Months Ended
June 30,
20262025
LeafAll OtherTotalLeafAll OtherTotal
Depreciation and amortization$5,237 $391 $5,628 $4,800 $369 $5,169 
Capital expenditures2,612 378 2,990 2,008 656 2,664 
June 30, 2026June 30, 2025March 31, 2026
LeafAll OtherTotalLeafAll OtherTotalLeafAll OtherTotal
Assets$1,975,994 $41,260 $2,017,254 $1,904,739 $35,786 $1,940,525 $1,660,016 $34,676 $1,694,692 
Trade and other receivables, net185,584 980 186,564 222,909 381 223,290 264,410 497 264,907 
Investments in unconsolidated affiliates89,676 6,498 96,174 89,198 6,461 95,659 99,239 6,624 105,863 
v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Basis of Presentation
The accompanying unaudited condensed consolidated interim financial statements represent the consolidation of Pyxus International, Inc. (the "Company," "Pyxus," "we," "us," or "our") and all companies that Pyxus directly or indirectly controls, either through majority ownership or otherwise. These condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, the normal and recurring adjustments necessary for a fair presentation of the results of operations, financial position, and cash flows have been included.

These condensed consolidated interim financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2026 filed on June 4, 2026. The year-end condensed consolidated balance sheet data was derived from the audited consolidated financial statements but does not include all disclosures required by U.S. GAAP. Due to the seasonal nature of the Company’s business, the results of operations for a fiscal quarter are not necessarily indicative of the operating results that may be attained for other quarters or a full fiscal year.
Accounting Pronouncements Not Yet Adopted
Accounting Pronouncements Not Yet Adopted
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2024-03, Disaggregation of Income Statement Expenses, which requires a tabular disclosure of relevant expense captions into prescribed natural expense categories. The annual disclosure requirements are effective for the Company’s fiscal year ending March 31, 2028, and the interim period disclosure requirements are effective beginning April 1, 2028. Early adoption is permitted. This new standard will result in additional disclosures within the footnotes to the financial statements, and is not expected to have an impact on the Company’s financial condition, results of operations, or cash flows.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software, which replaces the existing model used to determine when cost capitalization is to occur based on various project stages of software development with a more modern approach that introduces a probable-to-complete recognition threshold. The scope of this new guidance also includes the costs an entity incurs to implement a cloud computing arrangement as a customer. This amendment is effective for the Company's annual and interim periods beginning April 1, 2028. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.

In November 2025, the FASB issued ASU No. 2025-09, Hedge Accounting Improvements, to clarify certain aspects of existing hedge accounting guidance, and to more closely align hedge accounting with the economics of an entity's risk management activities. This amendment is effective for the Company’s annual and interim periods beginning April 1, 2027 and requires adoption on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.

In December 2025, the FASB issued ASU No. 2025-10, Accounting for Government Grants Received by Business Entities, to establish guidance on the recognition, measurement, and presentation of government grants received by business entities. This new guidance is effective for the Company’s fiscal year beginning April 1, 2029, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact this new accounting standard will have on its financial condition, results of operations, and cash flows.
v3.26.1
Revenue Recognition (Tables)
3 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue Disaggregated by Major Source The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:
Three Months Ended
June 30,
20262025
Leaf:
Product revenues$392,976 $458,238 
Processing and other revenues42,836 50,177 
Leaf sales and other operating revenues435,812 508,415 
All Other:
All Other sales and other operating revenues1,983 400 
Total sales and other operating revenues$437,795 $508,815 
v3.26.1
Loss Per Share (Tables)
3 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings (Loss) Per Share
The following summarizes the computation of loss per share:

Three Months Ended
June 30,
20262025
Net loss attributable to Pyxus International, Inc.$(7,280)$(15,825)
Basic weighted average shares outstanding26,056 25,670 
Plus: Dilutive equity awards(1)
— — 
Diluted weighted average shares outstanding26,056 25,670 
Loss per share:
Basic$(0.28)$(0.62)
Diluted$(0.28)$(0.62)
(1) For the three months ended June 30, 2026 and 2025, 34 shares and 264 shares, respectively, related to outstanding restricted stock units have been excluded from the computation of diluted earnings per share because their effect would be antidilutive.
v3.26.1
Trade Receivables, Net (Tables)
3 Months Ended
Jun. 30, 2026
Receivables [Abstract]  
Schedule of Allowance for Doubtful Accounts and Activity of Claims Allowances The following summarizes activity in the allowance for expected credit losses:
Three Months Ended
June 30,
20262025
Balance, beginning of period$(16,879)$(24,035)
Write-offs and other adjustments431 (264)
Balance, end of period(16,448)(24,299)
Trade receivables192,115 230,906 
Trade receivables, net$175,667 $206,607 
v3.26.1
Inventories, Net (Tables)
3 Months Ended
Jun. 30, 2026
Inventory Disclosure [Abstract]  
Schedule of Inventories, Net
The following summarizes the composition of inventories, net, with the All Other category primarily composed of non-tobacco agricultural products:

June 30, 2026June 30, 2025March 31, 2026
Processed tobacco$671,617 $575,922 $507,380 
Unprocessed tobacco393,542 513,882 279,348 
Other tobacco related27,847 26,089 26,883 
All Other
11,631 5,895 4,339 
Total$1,104,637 $1,121,788 $817,950 
v3.26.1
Equity Method Investments (Tables)
3 Months Ended
Jun. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments
The following summarizes the Company's equity method investments as of June 30, 2026:

Investee NameLocationPrimary PurposeOwnership Percentage
Basis Difference(1)
Adams International Ltd.ThailandPurchase and process tobacco49%$(4,526)
Alliance One Industries India Private Ltd.IndiaPurchase and process tobacco49%(5,770)
China Brasil Tabacos Exportadora S.A.BrazilPurchase and process tobacco49%43,000 
Oryantal Tütün Paketleme Sanayi ve Ticaret A.Ş.TurkeyProcess tobacco50%(416)
Purilum, LLCU.S.Produce flavor formulations and consumable nicotine products50%4,589 
Siam Tobacco Export Corporation Ltd.ThailandPurchase and process tobacco49%(6,098)
(1) Basis differences for the Company's equity method investments are due to fair value adjustments recorded during fiscal 2021.

The following summarizes financial information for these equity method investments:

Three Months Ended
June 30,
20262025
Statement of operations:
Sales$52,156 $46,504 
Gross profit6,256 7,052 
Net income (loss)3,007 (2,666)
June 30, 2026June 30, 2025March 31, 2026
Balance sheet:
Current assets$455,993 $510,324 $457,219 
Property, plant, and equipment and other assets67,568 51,932 65,716 
Current liabilities383,467 425,697 362,790 
Long-term obligations and other liabilities5,886 4,150 6,333 
v3.26.1
Variable Interest Entities (Tables)
3 Months Ended
Jun. 30, 2026
Variable Interest Entities [Abstract]  
Schedule of Variable Interest Entities The following summarizes the Company's financial relationships with its unconsolidated variable interest entities:
June 30, 2026June 30, 2025March 31, 2026
Investments in variable interest entities$89,676 $89,200 $99,239 
Receivables with variable interest entities1,913 1,469 — 
Guaranteed amounts to variable interest entities (not to exceed)18,449 15,968 18,483 
v3.26.1
Intangible Assets, Net (Tables)
3 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Schedule of Gross Carrying Amount and Accumulated Amortization of Intangible Assets
The gross carrying amount and accumulated amortization of intangible assets consist of the following:

June 30, 2026
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships6.2 years$26,101 $(12,688)$13,413 
Technology2.2 years11,618 (8,639)2,979 
Trade names8.2 years11,300 (4,708)6,592 
Total$49,019 $(26,035)$22,984 

June 30, 2025
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships7.2 years$26,101 $(10,513)$15,588 
Technology3.1 years11,618 (7,218)4,400 
Trade names9.2 years11,300 (3,901)7,399 
Total$49,019 $(21,632)$27,387 
March 31, 2026
Weighted Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
Intangibles subject to amortization:
Customer relationships6.4 years$26,101 $(12,144)$13,957 
Technology2.4 years11,618 (8,292)3,326 
Trade names8.4 years11,300 (4,507)6,793 
Total$49,019 $(24,943)$24,076 
Schedule of Amortization Expense for Definite-Lived Intangible Assets
The following summarizes amortization expense for definite-lived intangible assets:

Three Months Ended
June 30,
20262025
Amortization expense$1,092 $1,120 
v3.26.1
Debt Arrangements (Tables)
3 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Schedule of Debt Financing
The following summarizes debt and notes payable:

Interest Rate(1)
June 30, 2026June 30, 2025March 31, 2026
Senior secured credit facility:
ABL Credit Facility6.7 %$— $— $— 
Senior secured notes:
8.5% Notes Due 2027(2)
8.5 %146,908 146,046 146,662 
Senior secured term loans:
Intabex Term Loans(3)
12.2 %187,916 187,288 187,752 
Pyxus Term Loans(4)
12.2 %121,196 121,757 121,343 
Other debt:
   Notes payable(5)
9.0 %828,553 880,925 477,132 
    Total debt$1,284,573 $1,336,016 $932,889 
Short-term(5)
$828,553 $880,925 $477,132 
Long-term456,020 455,091 455,757 
Letters of credit$8,273 $8,939 $8,024 
(1) Weighted average stated rate for the trailing twelve months ended June 30, 2026 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.
(2) Balance of $146,908 is net of a debt discount of $1,431. Total repayment at maturity is $148,339.
(3) Balance of $187,916 is net of a debt discount of $1,117. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(4) Balance of $121,196 is net of a debt premium of $991. Total repayment at maturity is $120,205.
(5) Primarily foreign seasonal lines of credit.
v3.26.1
Securitized Receivables (Tables)
3 Months Ended
Jun. 30, 2026
Transfers and Servicing [Abstract]  
Schedule of Accounts Receivable Securitization Information
The following summarizes the Company’s accounts receivable outstanding in the securitization facilities, which represents trade receivables sold into the program that have not been collected from the customer, and related beneficial interests, applicable only to the first and second facilities, which represents the Company’s residual interest in receivables sold that have not been collected from the customer:

June 30, 2026June 30, 2025March 31, 2026
Receivables outstanding in facility$121,227 $167,433 $341,679 
Beneficial interests10,817 16,103 29,034 

Cash proceeds from the sale of trade receivables are comprised of an initial cash payment received at the time of transfer and a deferred purchase price receivable, applicable only to the first and second facilities, which represents the Company's right to receive the remaining consideration upon collection of the underlying trade receivables by the purchasers. The following summarizes the Company’s cash collections from both the initial cash proceeds and the deferred purchase price receivable:

Three Months Ended
June 30,
20262025
Cash collections from:
Initial proceeds$91,144 $115,034 
Deferred purchase price receivable58,540 41,007 
v3.26.1
Guarantees (Tables)
3 Months Ended
Jun. 30, 2026
Guarantees [Abstract]  
Schedule of Guarantees and Associated Fair Values See "Note 15. Fair Value Measurements" for the fair value of the Company's guarantee liability and corresponding fair value classification. The following summarizes amounts guaranteed:
June 30, 2026June 30, 2025March 31, 2026
Amounts guaranteed (not to exceed)$90,251 $83,519 $119,728 
Amounts outstanding under guarantee(1)
56,974 47,948 92,550 
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing7,691 7,478 10,204 
(1) The majority of the guarantees outstanding at June 30, 2026 expire within one year.
v3.26.1
Derivative Financial Instruments (Tables)
3 Months Ended
Jun. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The following summarizes the U.S. dollar notional amount of derivative contracts outstanding:

June 30, 2026June 30, 2025March 31, 2026
Foreign currency exchange contracts$49,267 $14,250 $54,100 
Schedule of Derivative Financial Instruments On Condensed Statements of Operations
The following summarizes the pre-tax effects of derivative financial instruments in the condensed consolidated statements of comprehensive loss and the condensed consolidated statements of operations:

Three Months Ended
June 30,
20262025
Foreign currency exchange contracts designated as cash flow hedges:
Gain recognized in accumulated other comprehensive income(1)
$1,298 $3,354 
Gain reclassified from accumulated other comprehensive income to earnings(2)
406 1,147 
Foreign currency exchange contracts not designated as hedging instruments:
Gain recognized in earnings(2)
$— $721 
(1) Amount represents the net change in fair value of derivative financial instruments.
(2) These net gains are recognized in cost of goods and services sold within the condensed consolidated statements of operations.
v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets And Liabilities Measured at Fair Value on a Recurring Basis
The following summarizes the financial assets and liabilities measured at fair value on a recurring basis, along with their corresponding level within the fair value hierarchy:    

June 30, 2026June 30, 2025March 31, 2026
Level 2Level 3Total
at Fair
Value
Level 2Level 3Total
at Fair
Value
Level 2Level 3Total
at Fair
Value
Financial Assets:
Derivative financial instruments$153 $— $153 $1,322 $— $1,322 $649 $— $649 
Securitized beneficial interests— 10,817 10,817 — 16,103 16,103 — 29,034 29,034 
Total assets$153 $10,817 $10,970 $1,322 $16,103 $17,425 $649 $29,034 $29,683 
Financial Liabilities:
Derivative financial instruments$100 $— $100 $— $— $— $— $— $— 
Long-term debt(1)
433,396 — 433,396 439,316 — 439,316 433,490 — 433,490 
Guarantees— 4,524 4,524 — 3,287 3,287 — 7,537 7,537 
Total liabilities$433,496 $4,524 $438,020 $439,316 $3,287 $442,603 $433,490 $7,537 $441,027 
(1) This fair value measurement disclosure does not affect the condensed consolidated balance sheets.
Schedule of Reconciliation of Changes in Level 3 Instruments
The following summarizes the changes in Level 3 instruments measured on a recurring basis:

Three Months Ended
June 30, 2026June 30, 2025
Securitized Beneficial InterestsLong-Term DebtGuaranteesSecuritized Beneficial InterestsLong-Term DebtGuarantees
Balance, beginning of period$29,034 $— $7,537 $29,354 $12 $6,459 
Issuances28,595 — 1,695 30,431 — 300 
Settlements(46,093)— (705)(42,023)(12)(1,242)
Losses recognized in earnings(719)— (4,003)(1,659)— (2,230)
Balance, end of period$10,817 $— $4,524 $16,103 $— $3,287 
v3.26.1
Equity-Based Compensation (Tables)
3 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity for Restricted Stock Units and Performance-Based Stock Units The following summarizes activity for restricted stock units:
(in thousands, except grant date fair value)Restricted Stock UnitsWeighted Average Grant Date Fair Value Per Share
Nonvested, March 31, 20261,749 $3.49 
Canceled or forfeited(8)3.50 
Nonvested, June 30, 20261,741 $3.49 
The following summarizes activity for performance-based stock units (at the target performance level):
(in thousands, except grant date fair value)Performance-Based Stock UnitsWeighted Average Grant Date Fair Value Per Share
Nonvested, March 31, 2026508 $4.47 
Canceled or forfeited(19)4.36 
Nonvested, June 30, 2026489 $4.47 
Schedule of Equity-Based Compensation Expense for Restricted Stock Units
The following summarizes equity-based compensation expense for restricted stock units, which is recorded in selling, general, and administrative expenses within the condensed consolidated statements of operations:

Three Months Ended
June 30,
20262025
Equity-based compensation expense$282 $237 
v3.26.1
Related Party Transactions (Tables)
3 Months Ended
Jun. 30, 2026
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions The following summarizes activities with the Company's equity method investees:
Three Months Ended
June 30,
20262025
Sales$7,791 $9,055 
Purchases20,385 27,309 
Dividends11,111 — 
Schedule of Related Party Balances in Condensed Consolidated Balance Sheets
The Company included the following related party balances in its condensed consolidated balance sheets:

June 30, 2026June 30, 2025March 31, 2026Location in Condensed Consolidated Balance Sheet
Accounts receivable, related parties$1,963 $1,519 $62 Other receivables
Accounts payable, related parties11,933 18,286 39,317 Accounts payable
Advances from related parties— 5,909 — Advances from customers
v3.26.1
Segment Information (Tables)
3 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Analysis of Segment and All Other Category Segment
The following summarizes financial information relating to the Leaf segment (the Company's sole reportable segment), with the All Other category included for purposes of reconciliation of the Leaf segment balances to the condensed consolidated financial statements:

Three Months Ended
June 30,
20262025
Sales and other operating revenues:
Leaf$435,812 $508,415 
All Other1,983 400 
Consolidated sales and other operating revenues$437,795 $508,815 
Cost of goods and services sold:
Leaf$375,691 $443,386 
All Other690 (197)
Consolidated cost of goods and services sold$376,381 $443,189 
Selling, general, and administrative expenses:
Leaf$42,631 $38,735 
All Other1,304 1,634 
Consolidated selling, general, and administrative expenses$43,935 $40,369 
Other segment items:(1)
Leaf$1,497 $4,205 
All Other(240)(29)
Consolidated other segment items$1,257 $4,176 
Leaf segment operating income$15,993 $22,089 
All Other operating income (loss)229 (1,008)
Restructuring and asset impairment charges557 81 
Consolidated operating income$15,665 $21,000 
Interest expense, net29,842 29,767 
Loss before income taxes and other items$(14,177)$(8,767)
(1) Represents the other expense, net caption within the condensed consolidated statements of operations.

Three Months Ended
June 30,
20262025
LeafAll OtherTotalLeafAll OtherTotal
Depreciation and amortization$5,237 $391 $5,628 $4,800 $369 $5,169 
Capital expenditures2,612 378 2,990 2,008 656 2,664 
June 30, 2026June 30, 2025March 31, 2026
LeafAll OtherTotalLeafAll OtherTotalLeafAll OtherTotal
Assets$1,975,994 $41,260 $2,017,254 $1,904,739 $35,786 $1,940,525 $1,660,016 $34,676 $1,694,692 
Trade and other receivables, net185,584 980 186,564 222,909 381 223,290 264,410 497 264,907 
Investments in unconsolidated affiliates89,676 6,498 96,174 89,198 6,461 95,659 99,239 6,624 105,863 
v3.26.1
Revenue Recognition - Schedule of Revenue Disaggregated by Major Source (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]    
Consolidated sales and other operating revenues $ 437,795 $ 508,815
Leaf    
Disaggregation of Revenue [Line Items]    
Consolidated sales and other operating revenues 435,812 508,415
Leaf | Product revenues    
Disaggregation of Revenue [Line Items]    
Consolidated sales and other operating revenues 392,976 458,238
Leaf | Processing and other revenues    
Disaggregation of Revenue [Line Items]    
Consolidated sales and other operating revenues 42,836 50,177
All Other    
Disaggregation of Revenue [Line Items]    
Consolidated sales and other operating revenues $ 1,983 $ 400
v3.26.1
Income Taxes (Details)
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Income Tax Disclosure [Abstract]    
Effective income tax rate (as a percent) 40.30% (59.60%)
v3.26.1
Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]    
Net loss attributable to Pyxus International, Inc. $ (7,280) $ (15,825)
Basic weighted average shares outstanding (in shares) 26,056 25,670
Plus: Dilutive equity awards (in shares) 0 0
Diluted weighted average shares outstanding (in shares) 26,056 25,670
Loss per share:    
Basic (in USD per share) $ (0.28) $ (0.62)
Diluted (in USD per share) $ (0.28) $ (0.62)
Restricted Stock Units    
Loss per share:    
Antidilutive securities excluded from computation of earnings per share (in shares) 34 264
v3.26.1
Trade Receivables, Net (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Allowance for Doubtful Accounts Receivable [Roll Forward]    
Balance, beginning of period $ (16,879) $ (24,035)
Write-offs and other adjustments 431 (264)
Balance, end of period (16,448) (24,299)
Trade receivables 192,115 230,906
Trade receivables, net $ 175,667 $ 206,607
v3.26.1
Inventories, Net (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Inventory Disclosure [Abstract]      
Processed tobacco $ 671,617 $ 507,380 $ 575,922
Unprocessed tobacco 393,542 279,348 513,882
Other tobacco related 27,847 26,883 26,089
All Other 11,631 4,339 5,895
Total $ 1,104,637 $ 817,950 $ 1,121,788
v3.26.1
Equity Method Investments (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Statement of operations:      
Gross profit $ 61,414 $ 65,626  
Net income (loss) (7,039) (15,263)  
Balance sheet:      
Current assets 1,652,948 1,591,001 $ 1,330,484
Current liabilities 1,262,323 1,216,816 932,775
Equity Method Investment      
Statement of operations:      
Sales 52,156 46,504  
Gross profit 6,256 7,052  
Net income (loss) 3,007 (2,666)  
Balance sheet:      
Current assets 455,993 510,324 457,219
Property, plant, and equipment and other assets 67,568 51,932 65,716
Current liabilities 383,467 425,697 362,790
Long-term obligations and other liabilities $ 5,886 $ 4,150 $ 6,333
Adams International Ltd.      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 49.00%    
Basis difference $ (4,526)    
Alliance One Industries India Private Ltd.      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 49.00%    
Basis difference $ (5,770)    
China Brasil Tabacos Exportadora S.A.      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 49.00%    
Basis difference $ 43,000    
Oryantal Tütün Paketleme Sanayi ve Ticaret A.Ş.      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 50.00%    
Basis difference $ (416)    
Purilum, LLC      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 50.00%    
Basis difference $ 4,589    
Siam Tobacco Export Corporation Ltd.      
Schedule of Equity Method Investments [Line Items]      
Ownership Percentage 49.00%    
Basis difference $ (6,098)    
v3.26.1
Variable Interest Entities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Variable Interest Entity [Line Items]      
Investments in variable interest entities $ 96,174 $ 105,863 $ 95,659
Receivables with variable interest entities 175,667   206,607
Variable Interest Entity, Not Primary Beneficiary      
Variable Interest Entity [Line Items]      
Investments in variable interest entities 89,676 99,239 89,200
Receivables with variable interest entities 1,913 0 1,469
Guaranteed amounts to variable interest entities (not to exceed) $ 18,449 $ 18,483 $ 15,968
v3.26.1
Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Schedule of Intangible Assets [Line Items]      
Gross Carrying Amount $ 49,019 $ 49,019 $ 49,019
Accumulated Amortization (26,035) (24,943) (21,632)
Intangible Assets, Net $ 22,984 $ 24,076 $ 27,387
Customer relationships      
Schedule of Intangible Assets [Line Items]      
Weighted Average Remaining Useful Life 6 years 2 months 12 days 6 years 4 months 24 days 7 years 2 months 12 days
Gross Carrying Amount $ 26,101 $ 26,101 $ 26,101
Accumulated Amortization (12,688) (12,144) (10,513)
Intangible Assets, Net $ 13,413 $ 13,957 $ 15,588
Technology      
Schedule of Intangible Assets [Line Items]      
Weighted Average Remaining Useful Life 2 years 2 months 12 days 2 years 4 months 24 days 3 years 1 month 6 days
Gross Carrying Amount $ 11,618 $ 11,618 $ 11,618
Accumulated Amortization (8,639) (8,292) (7,218)
Intangible Assets, Net $ 2,979 $ 3,326 $ 4,400
Trade names      
Schedule of Intangible Assets [Line Items]      
Weighted Average Remaining Useful Life 8 years 2 months 12 days 8 years 4 months 24 days 9 years 2 months 12 days
Gross Carrying Amount $ 11,300 $ 11,300 $ 11,300
Accumulated Amortization (4,708) (4,507) (3,901)
Intangible Assets, Net $ 6,592 $ 6,793 $ 7,399
v3.26.1
Intangible Assets, Net - Schedule of Amortization Expense for Definite-Lived Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Intangible Asset, Goodwill and Other [Abstract]    
Amortization expense $ 1,092 $ 1,120
v3.26.1
Debt Arrangements - Schedule of Debt Financing (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Feb. 06, 2023
Debt Instrument [Line Items]        
Total debt $ 1,284,573 $ 932,889 $ 1,336,016  
Short-term 828,553 477,132 880,925  
Long-term 456,020 455,757 455,091  
Letters of credit 8,273 8,024 8,939  
Face amount of debt instrument       $ 120,205
New Pyxus Credit Facility | 8.50% Senior Secured Notes Due 2027        
Debt Instrument [Line Items]        
Interest rate (as a percent)       8.50%
Face amount of debt instrument $ 148,339     $ 260,452
Intabex Term Loans | 8.5% Notes Due 2027        
Debt Instrument [Line Items]        
Original issue discount       1,117
Face amount of debt instrument       189,033
Debt instrument, fee amount       $ 2,000
Senior secured credit facility: | ABL Credit Facility        
Debt Instrument [Line Items]        
Interest rate (as a percent) 6.70%      
Total debt $ 0 0 0  
Senior secured notes: | 8.5% Notes Due 2027        
Debt Instrument [Line Items]        
Interest rate (as a percent) 8.50%      
Total debt $ 146,908 146,662 146,046  
Senior secured notes: | 8.50% Senior Secured Notes Due 2027        
Debt Instrument [Line Items]        
Interest rate (as a percent)       8.50%
Senior secured notes: | DDTL Term Loans        
Debt Instrument [Line Items]        
Original issue discount $ 1,431      
Intabex Term Loans        
Debt Instrument [Line Items]        
Weighted-average interest rate (as a percent) 12.20%      
Total debt $ 187,916 187,752 187,288  
Pyxus Term Loans        
Debt Instrument [Line Items]        
Weighted-average interest rate (as a percent) 12.20%      
Total debt $ 121,196 121,343 121,757  
Debt instrument, unamortized premium net $ 991      
Notes payable        
Debt Instrument [Line Items]        
Weighted-average interest rate (as a percent) 9.00%      
Total debt $ 828,553 $ 477,132 $ 880,925  
v3.26.1
Debt Arrangements - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
May 12, 2025
Feb. 06, 2023
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Feb. 08, 2022
Aug. 24, 2020
Debt Instrument [Line Items]              
Face amount of debt instrument   $ 120,205          
Total debt     $ 1,284,573 $ 932,889 $ 1,336,016    
Senior secured credit facility:              
Debt Instrument [Line Items]              
Maximum borrowing capacity     351,395        
Short-term debt, maximum outstanding amount     $ 150,630        
Minimum | Senior secured credit facility:              
Debt Instrument [Line Items]              
Debt instrument (in days)     180 days        
Maximum | Senior secured credit facility:              
Debt Instrument [Line Items]              
Debt instrument (in days)     365 days        
Senior secured notes: | 8.5% Notes Due 2027              
Debt Instrument [Line Items]              
Interest rate (as a percent)     8.50%        
Total debt     $ 146,908 $ 146,662 $ 146,046    
Senior secured notes: | 8.50% Senior Secured Notes Due 2027              
Debt Instrument [Line Items]              
Interest rate (as a percent)   8.50%          
Senior secured notes: | Senior Secured First Lien Notes due 2024              
Debt Instrument [Line Items]              
Shareholder election (as a percent)             92.70%
Debt instrument, outstanding (as a percent)             10.00%
ABL Credit Facility | Senior secured credit facility:              
Debt Instrument [Line Items]              
Maximum borrowing capacity $ 150,000            
Earliest redemption prior to stated maturity (in days) 90 days            
ABL Credit Facility | Revolving Loans Facilities              
Debt Instrument [Line Items]              
Maximum borrowing capacity           $ 170,000  
Additional borrowing capacity           $ 20,000  
Intabex Term Loans | 8.5% Notes Due 2027              
Debt Instrument [Line Items]              
Face amount of debt instrument   $ 189,033          
Intabex Term Loans | Term Loan Credit Agreement | Base Rate              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent)   7.00%          
Intabex Term Loans | Term Loan Credit Agreement | Minimum | Base Rate              
Debt Instrument [Line Items]              
Interest rate (as a percent)   1.50%          
Intabex Term Loans | Term Loan Credit Agreement | Maximum | SOFR              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent)   8.00%          
Pyxus Credit Facility | Term Loan Credit Agreement              
Debt Instrument [Line Items]              
Face amount of debt instrument   $ 130,550          
Pyxus Term Loans | Term Loan Credit Agreement | Base Rate              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent)   7.00%          
Pyxus Term Loans | Term Loan Credit Agreement | Minimum | Base Rate              
Debt Instrument [Line Items]              
Interest rate (as a percent)   1.50%          
Pyxus Term Loans | Term Loan Credit Agreement | Maximum | SOFR              
Debt Instrument [Line Items]              
Basis spread on variable rate (as a percent)   8.00%          
New Pyxus Credit Facility | 8.50% Senior Secured Notes Due 2027              
Debt Instrument [Line Items]              
Face amount of debt instrument   $ 260,452 148,339        
Interest rate (as a percent)   8.50%          
Foreign seasonal lines of credit | Senior secured credit facility:              
Debt Instrument [Line Items]              
Total debt     $ 1,170,392        
v3.26.1
Securitized Receivables - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
account
Jun. 30, 2025
USD ($)
Sep. 30, 2025
USD ($)
Mar. 31, 2026
USD ($)
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]        
Number of accounts with automatic annual renewal | account 2      
Receivables sold, face value discounted (as a percent) 100.00%      
Increase in designated receivable amount $ 40,000      
Receivable securitization programs, designated receivable amount 120,000      
Reductions of trade and other receivables due to settlements 10,817 $ 1,056 $ 13,610  
Accrued expenses and other current liabilities due to settlements $ 15,681 $ 0   $ 0
Accounts Receivable Securitization, Program One        
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]        
Servicing fee rate (as a percent) 0.50%      
Accounts Receivable Securitization, Program Two        
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]        
Receivable securitization programs, designated receivable amount $ 160,000      
v3.26.1
Securitized Receivables - Schedule of Accounts Receivable Securitization Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Transfers and Servicing [Abstract]      
Receivables outstanding in facility $ 121,227 $ 167,433 $ 341,679
Beneficial interests 10,817 16,103 $ 29,034
Cash collections from:      
Initial proceeds 91,144 115,034  
Deferred purchase price receivable $ 58,540 $ 41,007  
v3.26.1
Guarantees (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Guarantees [Abstract]      
Amounts guaranteed (not to exceed) $ 90,251 $ 119,728 $ 83,519
Amounts outstanding under guarantee 56,974 92,550 47,948
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing $ 7,691 $ 10,204 $ 7,478
Guarantor obligations (in years) 1 year    
v3.26.1
Derivative Financial Instruments - Schedule of Derivative Instruments (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Foreign currency exchange contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Foreign currency exchange contracts $ 49,267 $ 54,100 $ 14,250
v3.26.1
Derivative Financial Instruments - Schedule of Derivative Financial Instruments On Condensed Statements of Operations (Details) - Foreign currency exchange contracts - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Foreign currency exchange contracts designated as cash flow hedges:    
Foreign currency exchange contracts designated as cash flow hedges:    
Gain recognized in accumulated other comprehensive income $ 1,298 $ 3,354
Gain reclassified from accumulated other comprehensive income to earnings 406 1,147
Foreign currency exchange contracts not designated as hedging instruments:    
Foreign currency exchange contracts not designated as hedging instruments:    
Gain recognized in earnings $ 0 $ 721
v3.26.1
Fair Value Measurements - Schedule of Financial Assets And Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Financial Assets:      
Derivative financial instruments $ 153 $ 649 $ 1,322
Securitized beneficial interests 10,817 29,034 16,103
Total assets 10,970 29,683 17,425
Financial Liabilities:      
Long-term debt 433,396 433,490 439,316
Guarantees 4,524 7,537 3,287
Total liabilities $ 438,020 $ 441,027 $ 442,603
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets Other current assets
Estimate of Fair Value Measurement      
Financial Liabilities:      
Derivative financial instruments $ 100 $ 0 $ 0
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued expenses and other current liabilities
Level 2      
Financial Assets:      
Derivative financial instruments $ 153 $ 649 $ 1,322
Securitized beneficial interests 0 0 0
Total assets 153 649 1,322
Financial Liabilities:      
Long-term debt 433,396 433,490 439,316
Guarantees 0 0 0
Total liabilities 433,496 433,490 439,316
Level 2 | Estimate of Fair Value Measurement      
Financial Liabilities:      
Derivative financial instruments 100 0 0
Level 3      
Financial Assets:      
Derivative financial instruments 0 0 0
Securitized beneficial interests 10,817 29,034 16,103
Total assets 10,817 29,034 16,103
Financial Liabilities:      
Long-term debt 0 0 0
Guarantees 4,524 7,537 3,287
Total liabilities 4,524 7,537 3,287
Level 3 | Estimate of Fair Value Measurement      
Financial Liabilities:      
Derivative financial instruments $ 0 $ 0 $ 0
v3.26.1
Fair Value Measurements - Schedule of Reconciliation of Changes in Level 3 Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Long-Term Debt    
Long-Term Debt    
Balance, beginning of period $ 0 $ 12
Settlements 0 (12)
Losses recognized in earnings 0 0
Balance, end of period 0 0
Securitized Beneficial Interests    
Securitized Beneficial Interests and Guarantees    
Balance, beginning of period 29,034 29,354
Issuances 28,595 30,431
Settlements (46,093) (42,023)
Losses recognized in earnings (719) (1,659)
Balance, end of period 10,817 16,103
Guarantees    
Securitized Beneficial Interests and Guarantees    
Balance, beginning of period 7,537 6,459
Issuances 1,695 300
Settlements (705) (1,242)
Losses recognized in earnings (4,003) (2,230)
Balance, end of period $ 4,524 $ 3,287
v3.26.1
Contingencies and Other Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Oct. 26, 2007
Brazilian State of Parana | Tax Assessment    
Loss Contingencies [Line Items]    
Loss contingency, estimate of possible loss $ 11,538 $ 2,550
v3.26.1
Equity-Based Compensation - Narrative (Details)
$ in Thousands
3 Months Ended
Jun. 30, 2026
USD ($)
shares
2020 Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of remaining shares available for issuance (in shares) | shares 3,612,000
Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost | $ $ 668
Total unrecognized stock-based compensation, expected period (in years) 8 months 19 days
Performance-Based Stock Units | Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Performance based awards, target performance (as a percent) 0.00%
Performance-Based Stock Units | Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Performance based awards, target performance (as a percent) 200.00%
v3.26.1
Equity-Based Compensation - Schedule of Activity for Restricted Stock Units (Details) - Restricted Stock Units
shares in Thousands
3 Months Ended
Jun. 30, 2026
$ / shares
shares
Restricted Stock Units  
Nonvested, beginning balance (in shares) | shares 1,749
Canceled or forfeited (in shares) | shares (8)
Nonvested, ending balance (in shares) | shares 1,741
Weighted Average Grant Date Fair Value Per Share  
Nonvested, beginning balance (in USD per share) | $ / shares $ 3.49
Canceled or forfeited (in USD per share) | $ / shares 3.50
Nonvested, ending balance (in USD per share) | $ / shares $ 3.49
v3.26.1
Equity-Based Compensation - Schedule of Equity-Based Compensation Expense for Restricted Stock Units (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Restricted Stock Units    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Equity-based compensation expense $ 282 $ 237
v3.26.1
Equity-Based Compensation - Schedule of Activity for Performance-Based Stock Units (Details) - Performance-Based Stock Units
shares in Thousands
3 Months Ended
Jun. 30, 2026
$ / shares
shares
Performance-Based Stock Units  
Nonvested, beginning balance (in shares) | shares 508
Canceled or forfeited (in shares) | shares (19)
Nonvested, ending balance (in shares) | shares 489
Weighted Average Grant Date Fair Value Per Share  
Nonvested, beginning balance (in USD per share) | $ / shares $ 4.47
Canceled or forfeited (in USD per share) | $ / shares 4.36
Nonvested, ending balance (in USD per share) | $ / shares $ 4.47
v3.26.1
Related Party Transactions - Schedule of Related Party Transactions (Details) - Related Party - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Related Party Transaction [Line Items]    
Sales $ 7,791 $ 9,055
Purchases 20,385 27,309
Dividends $ 11,111 $ 0
v3.26.1
Related Party Transactions - Schedule of Related Party Balances in Condensed Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Related Party Transaction [Line Items]      
Accounts receivable, related parties $ 175,667 $ 239,456 $ 206,607
Accounts payable, related parties 114,644 146,828 124,341
Balance Sheet Location [Axis]: us-gaap:AccountsPayableCurrent | Related Party      
Related Party Transaction [Line Items]      
Accounts payable, related parties 11,933 39,317 18,286
Balance Sheet Location [Axis]: us-gaap:ContractWithCustomerLiabilityCurrent | Related Party      
Related Party Transaction [Line Items]      
Advances from related parties 0 0 5,909
Balance Sheet Location [Axis]: us-gaap:OtherReceivablesNetCurrent | Related Party      
Related Party Transaction [Line Items]      
Accounts receivable, related parties $ 1,963 $ 62 $ 1,519
v3.26.1
Related Party Transactions - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Aug. 31, 2024
Jun. 13, 2024
Mar. 25, 2024
Equity Method Investee            
Related Party Transaction [Line Items]            
Number of common stock owned by related party (in shares)           6,125
Interest payable, related parties $ 1,246 $ 1,499 $ 1,352      
Related Party            
Related Party Transaction [Line Items]            
Interest expense $ 5,182 $ 5,466        
Glendon Investor | Beneficial Owner            
Related Party Transaction [Line Items]            
Beneficial ownership (in shares)         8,315  
Ownership interest (as a percent)         33.80%  
Monarch Alternative Capital LP | Equity Method Investee            
Related Party Transaction [Line Items]            
Ownership interest (as a percent)           24.90%
Owl Creek Asset Management, LP | Beneficial Owner            
Related Party Transaction [Line Items]            
Beneficial ownership (in shares)       3,865    
Ownership interest (as a percent)       15.70%    
v3.26.1
Segment Information - Schedule of Analysis of Segment Information (Details)
$ in Thousands
3 Months Ended
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Reporting [Line Items]    
Consolidated sales and other operating revenues $ 437,795 $ 508,815
Consolidated cost of goods and services sold 376,381 443,189
Consolidated selling, general, and administrative expenses 43,935 40,369
Consolidated other segment items (1,257) (4,176)
Restructuring and asset impairment charges 557 81
Consolidated operating income 15,665 21,000
Interest expense, net 29,842 29,767
Loss before income taxes and other items $ (14,177) (8,767)
Number of reportable segments | segment 1  
Operating Segments    
Segment Reporting [Line Items]    
Consolidated sales and other operating revenues $ 437,795 508,815
Consolidated cost of goods and services sold 376,381 443,189
Consolidated selling, general, and administrative expenses 43,935 40,369
Consolidated other segment items 1,257 4,176
Leaf    
Segment Reporting [Line Items]    
All Other operating income (loss) 15,993 22,089
Leaf | Operating Segments    
Segment Reporting [Line Items]    
Consolidated sales and other operating revenues 435,812 508,415
Consolidated cost of goods and services sold 375,691 443,386
Consolidated selling, general, and administrative expenses 42,631 38,735
Consolidated other segment items 1,497 4,205
All Other    
Segment Reporting [Line Items]    
All Other operating income (loss) 229 (1,008)
All Other | Operating Segments    
Segment Reporting [Line Items]    
Consolidated sales and other operating revenues 1,983 400
Consolidated cost of goods and services sold 690 (197)
Consolidated selling, general, and administrative expenses 1,304 1,634
Consolidated other segment items $ (240) $ (29)
v3.26.1
Segment Information - Schedule of All Other Category Segment (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]      
Depreciation and amortization $ 5,628 $ 5,169  
Capital expenditures 2,990 2,664  
Assets 2,017,254 1,940,525 $ 1,694,692
Trade and other receivables, net 186,564 223,290 264,907
Investments in unconsolidated affiliates 96,174 95,659 105,863
Leaf      
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]      
Depreciation and amortization 5,237 4,800  
Capital expenditures 2,612 2,008  
Assets 1,975,994 1,904,739 1,660,016
Trade and other receivables, net 185,584 222,909 264,410
Investments in unconsolidated affiliates 89,676 89,198 99,239
All Other      
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]      
Depreciation and amortization 391 369  
Capital expenditures 378 656  
Assets 41,260 35,786 34,676
Trade and other receivables, net 980 381 497
Investments in unconsolidated affiliates $ 6,498 $ 6,461 $ 6,624